A randomized trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy.

Beteiligte Wissenschaftler:
Akad. Rat Dr. Dipl.-Stat. J. Gerß

Studienleitung:
Dr. Neyssa Marina
Prof. Dr. Stefan Bielack
Dr. Sigbjørn Smeland
Dr. Jeremy Whelan